| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 298 | 0 | 5.651 | 0 | 0 | 1.516 | 0 |
| Total Income - EUR | - | - | 0 | 20.126 | 11.000 | 12.767 | 0 | 0 | 1.516 | 0 |
| Total Expenses - EUR | - | - | 3.212 | 20.692 | 23.628 | 18.705 | 19 | 0 | 0 | 256 |
| Gross Profit/Loss - EUR | - | - | -3.212 | -566 | -12.628 | -5.938 | -19 | 0 | 1.516 | -256 |
| Net Profit/Loss - EUR | - | - | -3.212 | -569 | -12.628 | -5.989 | -19 | 0 | 1.274 | -256 |
| Employees | - | - | 1 | 2 | 2 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Evogenic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 80 | 18.614 | 7.253 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 47 | 3.337 | 100 | 0 | 0 | 0 | 1.516 | 19 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | 47 | 3.337 | 100 | 0 | 0 | 0 | 1.516 | 19 |
| Shareholders Funds | - | - | -3.168 | -3.680 | -16.237 | -21.918 | -21.451 | -21.517 | -20.178 | -20.321 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 3.296 | 7.017 | 16.356 | 21.938 | 21.451 | 21.517 | 21.695 | 20.340 |
| Income in Advance | - | - | 0 | 18.614 | 7.253 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3299 - 3299" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Evogenic Srl